 |
Cytomegalovirus immune globulin intravenous (human) |
|---|---|
| Trade Name | |
| Orphan Indication | For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients |
| USA Market Approval | USA |
| USA Designation Date | 1991-01-28 00:00:00 |
| Sponsor | Bayer Corporation;Pharmaceutical Division, Biological Products, 400 Morgan Lane;New Haven, Connecticut, 06516 |
